Altimmune shares pop as analysts see obesity-drug partnership potential
Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its promising experimental weight-loss drug.
Source: marketwatch.com
Page 34 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Service Testing Today - Breaking & Trending Today
Health Care Slips on Rotation Into Rate-Sensitive Sectors -- Health Care Roundup
Health-care companies fell as traders rotated into sectors with more to gain from a shift in Federal Reserve policy. Drug giant Merck & Co. pulled the...
Source: marketwatch.com
Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials
By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...
Source: marketwatch.com
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...
Source: marketwatch.com
Replimune's RP1 Carcinoma Trial Fails to Meet Primary Endpoints
By Dean Seal A clinical trial of Replimune Group's RP1 as a treatment for cutaneous squamous cell carcinoma failed to meet its primary endpoints. The...
Source: marketwatch.com